Huge milestone! Dual action technology catheter + efficient smart blood return system now commercially available
Just one week after clearance, our first four commercial Hēlo® cases are complete.
Over the past four days, Dr. George So and the team at @TMHealthSystem completed the first four commercial procedures with the Hēlo® Thrombectomy System.
We're grateful for the care they provide for their patients, and proud that Hēlo® is helping patients in need.
Four patients treated, and many more to come.
Rx Only. Clinical outcomes may vary. Learn more: bit.ly/4BjLN6Q
18
Justin Oskey retweeted
How are new catheter-based thrombectomy and blood return technologies transforming pulmonary embolism care?
In this episode, Dr. Julie Bulman (@juliecbulman) and Dr. Jay Giri (@jaygirimd) join us to break down PERT strategies for patient classification, techniques and devices in aspiration thrombectomy, and how blood return mechanisms are transforming the way define therapeutic endpoints in PE management.
Watch the full episode on the BackTable app: na2.hubs.ly/H07YR-n0
This podcast is supported by Endovascular Engineering.
#VI677 #CV53 #PERT #PulmonaryEmbolism #InterventionalRadiology #Thrombectomy #Medicine @beckcj @PERTConsortium @BIDMCVIR @PennMedicine
Justin Oskey retweeted
The Spanish broadcast call for Messi's assist and Lautaro's header was ELECTRIC 🗣️🔥
(via @TelemundoSports)
Justin Oskey retweeted
From access to outcome in 10 minutes.
@DCNeurosurgeon Ehsan Dowlati, MD, at @MedStarWHC achieves TICI 3 reperfusion in an M1 occlusion using FC 70.
#thepoweroftenzing
Justin Oskey retweeted
Dr. Young Lee at University Medical Center New Orleans shows what’s possible with the super-bore #HiPoint 88 Reperfusion System using the #Monopoint Approach delivered through the 8F #BaseCamp 2.0 Sheath. First-pass success and successful delivery to the M1 occlusion with #TICI3 results. Thank you for sharing! Learn more about HiPoint 88 Reperfusion System: route92medical.com/hipoint-r…
Justin Oskey retweeted
New #SUMMIT_MAX data: Outcomes from the FIRST multicenter, randomized controlled trial for aspiration thrombectomy—using the super-bore #HiPoint 88 Reperfusion Catheter and the #Tenzing 8 Delivery Catheter featuring the #Monopoint Approach— now available at #ESOC booth #D4.
Justin Oskey retweeted
We are excited to announce that Inari Medical entered into a definitive agreement to be acquired by Stryker.
Joining the Stryker family will allow us to build on our tremendous progress in pioneering an entirely new approach to helping patients with Venous Thromboembolism.
Press Release (Important Info): ir.inarimedical.com/news-rel…
Justin Oskey retweeted
Superior clinical evidence and the lowest episode care costs make #ClotTriever the intelligent choice for #DVT thrombectomy. Check out the recent #JVS-VI publication that showed total care costs were $3,400 less with ClotTriever compared to continuous aspiration thrombectomy for #DVT treatment.
Learn more: bit.ly/3BwW3yh
Justin Oskey retweeted
🆕📖Results from an analysis of #DVT pts in the PINC AI Healthcare Database suggest that different #MechanicalThrombectomy devices may be unequal in outcomes, resources, & cost. 💡
Read more here:
➡️doi.org/10.1016/j.jscai.2024…
@CMichaelGibson @sahilparikhmd
#DeepVeinThrombosis
Justin Oskey retweeted
UNBELIEVABLE PLAYOFF DRAMA!
Adam Scott chips in and Cam Davis shows nerves of steel by rolling a birdie right behind him!
Justin Oskey retweeted
"It seems like Tommy Shelby wasn't finished with me..." - Cillian Murphy
A #PeakyBlinders film is coming to Netflix!
Justin Oskey retweeted
🎙️Listen in as Drs. @NickMouawadMD & @RajWellnessMD chat about #CLOUT and the changing landscape of #DVT management.
#deepveinthrombosis #VTE
Today on BackTable: @NickMouawadMD and @RajWellnessMD discuss the take home points from the CLOUT registry 2 year data for treatment of DVT #medEd #VI451 @noorahmadmd @SDhandMD @NLamparello @InariMedical @SIR_ECS @sdabramowitz @kush_r_desai @bahetimd open.spotify.com/episode/2P1…
Justin Oskey retweeted
New Premier PE real-world evidence presented at #SIR2024 comparing PE patients treated w/ #FlowTriever System to those treated w/ Penumbra Indigo System:
- 4,000+ real-world PE patients treated with FlowTriever or Penumbra Indigo analyzed
- Groups adjusted to account for population differences
- Patients treated with FlowTriever showed significantly lower rates of in-hospital mortality, less adjunctive use of lytics
#PINCAI
Learn more: onlinelibrary.wiley.com/doi/…
Justin Oskey retweeted
📣 Exciting News Alert!
We're delighted to introduce two new additions to our team: Tim Benner, now serving as Senior VP of U.S. Sales, and Dr. @AndrewNiekampMD, our new VP of Medical Affairs!
For more: bit.ly/43MrRtc
Justin Oskey retweeted
RLE #DVT treated with #ClotTrieverBOLD. Check out this case from Dr. Trung Bui highlighting #CTBOLD's unique design & mechanism of action for the removal of acute to chronic #clot.
✔ Single-session treatment
✔ 20 mL EBL
✔ No tPA
#NoChannels #NoCompromise #walltowall
More info on CT: bit.ly/3LHaguE
Justin Oskey retweeted
We’re excited to announce that Inari Medical has agreed to acquire #LimFlow, a medical device company focused on transforming the treatment of CLTI, an advanced stage of peripheral artery disease. We look forward to welcoming LimFlow to the #InariMedical family!
Read more here: ir.inarimedical.com/news-rel…
Justin Oskey retweeted
Humbled and honored to share that more than 100,000 patients have been treated with an Inari Medical device. Thank you to the many people who have contributed along the way to treat and transform the lives of patients suffering from venous disease.
Justin Oskey retweeted
#Revcore thrombectomy device provides new option for chronically occluded venous stents. @InariMedical @CLTRadiology @SIRspecialists @SIRRFS



















